Page last updated: 2024-10-21

tacrine and Alogia

tacrine has been researched along with Alogia in 1 studies

Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders.
tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease.

Research Excerpts

ExcerptRelevanceReference
") produced amnesia in the passive avoidance task, chronic administration of tacrine (1, 3 and 10 mg/kg, once a day for 1 week) improved the amnesia."1.28The effect of tacrine (THA) on cycloheximide- and basal forebrain lesion-induced memory deficit in rats. ( Kameyama, T; Katoh, A; Maruyama, E; Nabeshima, T, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nabeshima, T1
Maruyama, E1
Katoh, A1
Kameyama, T1

Other Studies

1 other study available for tacrine and Alogia

ArticleYear
The effect of tacrine (THA) on cycloheximide- and basal forebrain lesion-induced memory deficit in rats.
    Japanese journal of pharmacology, 1991, Volume: 57, Issue:3

    Topics: Administration, Oral; Amnesia; Animals; Aphasia; Ataxia; Avoidance Learning; Behavior, Animal; Brain

1991